Related Experiment Videos
[TSH anti-receptor antibodies in Graves' disease]
M R Sérgio1, C Godinho, L Guerra
1Laboratório Endocrinologia, Serviço Patologia Clínica, Unidade Endocrinologia do Hospital Curry Cabral, Lisboa.
Abstract:
The purpose of this study was to evaluate the sensitivity, specificity and predictive value of thyrotropin receptor antibody (TRAb) in the diagnosis of Graves disease. TRAb was tested by an isotopic receptor assay-TRAK Henning-in 80 newly diagnosed, untreated Graves disease patients (group I), 63 with other thyroid diseases (group II) and 60 controls (group III). In group I, 11 patients were TRAb negative and 7 were considered in the gray area (TRAb between 9 and 14 U/L). In group II, only 2 patients had TRAb 9 U/l and all controls were TRAb negative. For statistical analysis patients with TRAb in gray area were excluded. Sensitivity and specificity for this assay were 84.5 and 100% respectively. Predictive value of 100% affords certainty that a hyperthyroid patient with a positive TRAb has Graves disease, not sequining a scintigram.
Insights
Thyrotropin receptor antibody (TRAb) testing demonstrates high accuracy in diagnosing Graves disease. This assay shows 84.5% sensitivity and 100% specificity, confirming Graves disease in hyperthyroid patients.
Area of Science:
- Endocrinology
- Immunology
- Diagnostic Medicine
Context:
- Graves disease is an autoimmune disorder causing hyperthyroidism.
- Accurate diagnosis is crucial for effective management.
- Thyrotropin receptor antibodies (TRAb) are key biomarkers.
Purpose:
- To assess the diagnostic performance of TRAb testing.
- Evaluate sensitivity, specificity, and predictive value of the TRAK Henning assay.
- Compare TRAb levels in Graves' disease patients, other thyroid conditions, and healthy controls.
Summary:
- The study analyzed 80 new Graves' disease patients, 63 with other thyroid diseases, and 60 controls.
- TRAb testing via the TRAK Henning assay showed 84.5% sensitivity and 100% specificity.
- A 100% predictive value confirms Graves' disease in positive cases, aiding differential diagnosis.
Impact:
- Establishes TRAb testing as a reliable diagnostic tool for Graves' disease.
- Offers a definitive diagnosis, potentially reducing the need for scintigraphy.
- Improves patient management by providing diagnostic certainty.